References
- Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. Platelet-activating factor (PAF). A review of its effects, antagonists and possible future clinical implications. Drugs 1991; 42: 9–29; 174–204
- De Feudis F V. Ginkgo biloba Extract (EGb 761). Pharmacological Activities and Clinical Applications. Elsevier, Paris 1991; 187
- Marak G E, De Kozak Y, Faure J P. Free radicals and antioxidants in the pathogenesis of eye diseases. Antioxidants in Therapy and Preventive Medicine, I Emerit. Plenum Press, New York 1990; 513–527
- Szabo M E, Droy-Lefaix M T, Doly M, Carré C, Braquet P. Ischaemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism. Invest Ophthalmol Vis Sci 1991; 32: 1471–1478
- Domingo M T, Chabrier P E, VanDelft J L, Verbey N L, VanHaeringen N J, Braquet P. Characterization of specific binding sites for PAF in the iris and ciliary body of rabbit. Biochem Biophys Res Commun 1989; 160: 250–256
- Thierry A, Doly M, Braquet P, Cluzel J, Meyniel G. Presence of specific platelet-activating factor binding sites in the rat retina. Eur J Pharmacol 1989; 163: 91–97
- Bazan H EP, Reddy S TK, Woodland J M, Bazan N G. The accumulation of platelet-activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. Biochem Biophys Res Commun 1987; 149: 915–920
- Bazan H EP, Braquet P, Reddy S TK, Bazan N G. Inhibition of the alkali burn induced lipoxygenation of arachidonic acid in the rabbit cornea in vivo by a platelet-activating factor antagonist. J Ocular Pharmacol 1987; 3: 357–365
- Bazan H EP, Tao Y, Bazan N G. Platelet-activating factor induces collagenase expression in corneal epithelial cells. Proc Natl Acad Sci USA 1993; 90: 8678–8682
- Gautheron P D, Coulbault L, Sugrue M F. A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L 652,731. J Pharm Pharmacol 1987; 39: 857–859
- Yousufzai S YK, Abdel-Latif A A. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Biochem J 1985; 228: 697–706
- Verbey N L, VanDelft J L, VanHaeringen N J, Braquet P. Platelet-activating factor and laser trauma of the iris. Invest Ophthalmol Vis Sci 1989; 30: 1101–1103
- Lin N, Bazan H EP, Braquet P, Bazan N G. Prolonged effect of a new platelet-activating factor antagonist on ocular vascular permeability in an endotoxin model of uveitis. Curr Eye Res 1991; 10: 19–24
- Bussolino F, Torelli S, Stefanini E, Gremo F J. Platelet activating factor production occurs through stimulation of cholinergic and dopaminergic receptors in the chick retina. J Lipid Mediat 1989; 1: 283–288
- Doly M, Gaillard G, Braquet P. Electroretinogram and mediators of inflammation. New Trends Lipid Mediator Res 1990; 5: 149–167
- Doly M, Millerin M, Bonhomme B, Droy-Lefaix M T, Braquet P. Inhibition of vincristin-induced retinal impairments by a specific PAF antagonist. Lens and Eye Toxicity Res 1992; 9: 529–535
- Doly M, Cluzel J, Millerin M, Bonhomme B, Braquet P. Prevention of chloroquine-induced electroretinographic damage by a new platelet activating factor antagonist, BN 50730. Ophthalmic Res 1993; 25: 314–318
- Millerin M, de Kozak Y, Doly M, Bonhomme B, Braquet P. Prévention de la dégénérescence rétinienne du rat RCS par un antagoniste spécifique du PAF, le BN 50730. Neurobiologie de la Rétine, Y Christen, M Doly, M T Droy-Lefaix. Elsevier, Paris 1992; 202–207
- Remé C, Wei Q, Munz K, Jung H, Doly M, Droy-Lefaix M T. Light and lithium effects in the rat retina: modification by the PAF antagonist BN 52021. Graefe's Arch Clin Exp Ophthalmol 1992; 230: 580–588
- Dorey C, Cozette J, Faure J P. A simple and rapid method for isolation of retinal S-antigen. Ophthalmic Res 1982; 14: 249–255
- de Kozak Y, Sakai J, Thillaye B, Faure J P. S-antigen-induced experimental autoimmune uveoretinitis in rats. Curr Eye Res 1981; 1: 327–337
- de Kozak Y, Mirshahi M, Boucheix C, Faure J P. Prevention of experimental autoimmune uveoretinitis by active immunization with autoantigen-specific monoclonal antibodies. Eur J Immunol 1987; 17: 541–547
- Rao N A. Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans Am Ophthalmol Soc 1990; 88: 797–850
- Droy-Lefaix M T, Doly M. EGb 761, a retina free-radical scavenger. Effects of Ginkgo biloba extract (EGb 761) on the Central Nervous System, Y Christen, J Costentin, M Lacour. Elsevier, Paris 1992; 7–17